secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001193125-26-159289
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines raises ~$2.15B via equity and convertible note offerings
-----------------------------------------------------------------------------

- Equity offering: 10,563,381 shares at $142/sh + full over-allotment of 1,584,506 shares; net proceeds ~$1.65B.
- Convertible note offering: $500M aggregate principal of 0.50% Convertible Senior Notes due 2033.
- Equity closed April 16; note offering expected to close April 17; underwriters J.P. Morgan, TD Securities, Guggenheim.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312526159289/0001193125-26-159289-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312526159289/d95226d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-159289

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer